CO103 Modelled Impact of Nirsevimab for All Infants in Preventing Respiratory Syncytial Virus (RSV): Related Hospitalizations and Costs in the Brazilian Private Healthcare System
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.175
https://www.valueinhealthjournal.com/article/S1098-3015(23)03305-3/fulltext
Title :
CO103 Modelled Impact of Nirsevimab for All Infants in Preventing Respiratory Syncytial Virus (RSV): Related Hospitalizations and Costs in the Brazilian Private Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03305-3&doi=10.1016/j.jval.2023.09.175
First page :
Section Title :
Open access? :
No
Section Order :
11179